首页> 外文期刊>HIV/AIDS: Research and Palliative Care >Ocular surface squamous neoplasia in HIV-infected patients: current perspectives
【24h】

Ocular surface squamous neoplasia in HIV-infected patients: current perspectives

机译:HIV感染患者的眼表鳞状上皮增生:当前观点

获取原文
获取外文期刊封面目录资料

摘要

Ocular surface squamous neoplasia (OSSN) refers to a spectrum of conjunctival and corneal epithelial tumors including dysplasia, carcinoma in situ, and invasive carcinoma. In this article, we discuss the current perspectives of OSSN associated with HIV infection, focusing mainly on the epidemiology, pathophysiology, clinical manifestations, diagnosis, and treatment of these tumors in patients with HIV. Upsurge in the incidence of OSSN with the HIV pandemic most severely affected sub-Saharan Africa, due to associated risk factors, such as human papilloma virus and solar ultraviolet exposure. OSSN has been reported as the first presenting sign of HIV/AIDS in 26%–86% cases, and seropositivity is noted in 38%–92% OSSN patients. Mean age at presentation of OSSN has dropped to the third to fourth decade in HIV-positive patients in developing countries. HIV-infected patients reveal large aggressive tumors, higher-grade malignancy, higher incidence of corneal, scleral, and orbital invasion, advanced-stage T4 tumors, higher need for extended enucleation/exenteration, and increased risk of tumor recurrence. Current management of OSSN in HIV-positive individuals is based on standard treatment guidelines described for OSSN in the general population, as there is little information available about various treatment modalities or their outcomes in patients with HIV. OSSN can occur at any time in the disease course of HIV/AIDS, and no significant trend has been discovered between CD4 count and grade of OSSN. Furthermore, the effect of highly active antiretroviral therapy on OSSN is controversial. The current recommendation is to conduct HIV screening in all cases presenting with OSSN to rule out undiagnosed HIV infection. Patient counseling is crucial, with emphasis on regular follow-up to address high recurrence rates and early presentation to an ophthalmologist for of any symptoms in the unaffected eye. Effective evidence-based interventions are needed to allow early diagnosis and treatment, as well as prevention of the disease.
机译:眼表面鳞状上皮瘤(OSSN)是指结膜和角膜上皮肿瘤的频谱,包括不典型增生,原位癌和浸润性癌。在本文中,我们讨论了与HIV感染相关的OSSN的当前观点,主要集中在HIV患者中这些肿瘤的流行病学,病理生理学,临床表现,诊断和治疗。由于人类乳头瘤病毒和日光紫外线照射等相关风险因素,受艾滋病毒大流行影响最严重的撒哈拉以南非洲OSSN的发病率上升。据报道,OSSN在26%至86%的病例中是HIV / AIDS的第一个表现体征,在38%至92%的OSSN患者中发现了血清阳性。在发展中国家,艾滋病毒抗体阳性患者出现OSSN的平均年龄已降至第三至第四十年。感染了HIV的患者显示出侵袭性肿瘤较大,恶性程度更高,角膜,巩膜和眼眶侵袭的发生率更高,晚期T4肿瘤,对更大范围的摘除/切开术的需求增加以及肿瘤复发的风险增加。 HIV阳性患者目前对OSSN的治疗基于针对普通人群中描述的OSSN的标准治疗指南,因为关于HIV患者的各种治疗方式或治疗效果的信息很少。 OSSN可以在HIV / AIDS的疾病过程中的任何时间发生,并且CD4计数与OSSN等级之间没有发现显着趋势。此外,高活性抗逆转录病毒疗法对OSSN的作用引起争议。当前的建议是在所有出现OSSN的病例中进行HIV筛查,以排除未确诊的HIV感染。患者咨询至关重要,其重点在于定期随访以解决高复发率,并尽早就不受影响的眼部症状向眼科医生提出。需要有效的基于证据的干预措施,以便及早诊断和治疗以及预防疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号